Product Details
Capecitabine + Docetaxel, Oral Regimen, for Tablets BP
Product Name
:
Capecitabine + Docetaxel, Oral Regimen, for Tablets BP
Brand Name
:
VERCAP-D
Available Strength
:
Capecitabine BP 500 mg + Docetaxel BP 20 mg
Packing
:
60 Tablets
Pack Insert/Leaflet
:
According To Your Needs
This oral formulation combines two chemotherapy agents used in solid tumor treatment protocols. Oncologists prescribe capecitabine- and docetaxel-based regimens under close supervision, with dosing and cycling tailored to each patient.
The tablets combine:
- Capecitabine BP (500 mg) — an antimetabolite prodrug that converts to 5-fluorouracil within tumor tissue, disrupting DNA synthesis in cancer cells
- Docetaxel BP (20 mg) — a taxane that stabilizes microtubules, blocking cell division in rapidly proliferating cancer cells
Together, these two agents target cancer cell growth through complementary mechanisms. Oncology specialists administer capecitabine- and docetaxel-based regimens under strict clinical protocols, with dosing individualized to each patient’s treatment plan.
Key Features
- Formulated to BP (British Pharmacopoeia) standards
- Combines an antimetabolite prodrug with a taxane in a single oral dosage form
- Manufactured under GMP-compliant, high-alert medication handling protocols
- Intended strictly for use under oncologist supervision
- Tablets should not be crushed or chewed
- Restricted to hospital, oncology clinic, and specialist institutional supply